Alpha 2.0
Login Register
» Articles » PMID: 19116023

Sudden Loss of Visual Acuity Following Intra-articular Steroid Injection in to the Knee Joint: a Case Report

Overview
Journal Cases J
Specialty General Medicine
Date 2009 Jan 1
PMID 19116023
Citations 7
Authors
Saikrishna Balakrishnan
Sunil Apsingi
Sanjiv B Manjure
Affiliations
Soon will be listed here.
Abstract

Background: Exogenous and endogenous steroids have been implicated in the pathogenesis of central serous choroioretinopathy in the literature. Central serous choroioretinopathy presents as sudden reduction in visual acuity.

Case Presentation: Despite the fact that steroid injections are so commonly used in the Orthopaedics there is no information regarding central serous chorioretinopathy in Orthopaedic literature. We report a case of acute onset central serous chorioretinopathy following an intra-articular injection.

Conclusion: Orthopaedic surgeons and doctors dealing with Musculoskeletal problems need to be aware of this unusual complication of systemic steroid therapy and refrain from administering further steroids to patients with history of blurring of vision or sudden loss of visual acuity following previous steroid injections.

Citing Articles

Serial Intralesional Steroid Injection for Subglottic Stenosis: Systemic Side Effects and Impact on Surgery-Free Interval.

Neevel A, Schuman A, Morrison R, Hogikyan N, Kupfer R OTO Open. 2021; 5(4):2473974X211054842.

PMID: 34734156 PMC: 8558814. DOI: 10.1177/2473974X211054842.

Central Serous Chorioretinopathy: A Complication Associated with Behçet’s Disease Treatment.

Doganay N, Yilmaz M, Orduyilmaz B, Aydin E, Saatci A Turk J Ophthalmol. 2019; 49(1):40-43.

PMID: 30829024 PMC: 6416479. DOI: 10.4274/tjo.galenos.2018.83479.

Development of Central Serous Chorioretinopathy following Chalazion Removal with Intralesional Triamcinolone Injection: A Case Report.

Rosignoli L, Potter S, Gonzalez A, Amin S, Khurshid S Case Rep Ophthalmol. 2018; 9(3):416-420.

PMID: 30323759 PMC: 6180267. DOI: 10.1159/000492714.

Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Lai T, Wong R, Chan W Trans Am Ophthalmol Soc. 2016; 113:T8.

PMID: 26755855 PMC: 4692328.

Steroid-induced central serous chorioretinopathy in a patient with non-arteritic anterior ischemic optic neuropathy.

Alkin Z, Yilmaz I, Ozkaya A, Yazici A Saudi J Ophthalmol. 2015; 29(3):232-4.

PMID: 26155086 PMC: 4487943. DOI: 10.1016/j.sjopt.2015.01.002.

References
1.
GASS J, Little H . Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology. 1995; 102(5):737-47. DOI: 10.1016/s0161-6420(95)30960-8. View
2.
Tittl M, Spaide R, Wong D, Pilotto E, Yannuzzi L, Fisher Y . Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol. 1999; 128(1):63-8. DOI: 10.1016/s0002-9394(99)00075-6. View
3.
Bouzas E, Karadimas P, Pournaras C . Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002; 47(5):431-48. DOI: 10.1016/s0039-6257(02)00338-7. View
4.
Mondal L, Sarkar K, Datta H, Chatterjee P . Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid. Indian J Ophthalmol. 2005; 53(2):132-4. DOI: 10.4103/0301-4738.16181. View
5.
Garg S, Dada T, Talwar D, Biswas N . Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol. 1998; 81(11):962-4. PMC: 1722041. DOI: 10.1136/bjo.81.11.962. View